By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Interleukin Genetics today said that the corporate compliance staff of the New York Stock Exchange Amex has granted the firm an extension to meet the exchange's continued listing standards.

The Waltham, Mass.-based genetic test maker will remain listed on the NYSE Amex up to June 23, subject to periodic review by the exchange staff of the firm's progress toward regaining compliance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.